23andMe CEO: We Fell Behind In Our Communications With The FDA
Advertisement
Owen Thomas, Business Insider
Advertisement
"We're working aggressively with the FDA," Wojcicki told Bloomberg.
There should be a way for companies to market genetic testing directly to consumers, Wojcicki said, and some sort of way that everyone can get access to their genome. (Currently, consumers have to visit their doctor if they want testing.)
Complimentary Tech Event
Transform talent with learning that works
Capability development is critical for businesses who want to push the envelope of innovation.Discover how business leaders are strategizing around building talent capabilities and empowering employee transformation.Know More
Late last month, the FDA demanded 23andMe in a warning letter to stop marketing its DNA testing device. 23andMe has also since been slapped with a $5 million class action lawsuit.
Check out the full interview here.
Advertisement
Advertisement
- Tabu to work in Hollywood again, bags pivotal role in international series 'Dune: Prophecy'
- Digital Marketing for E-Commerce
- Indian stocks in green for second day after heavy sell-off
- Asia to contribute 60 pc of global growth in 2024: IMF official
- India's retail inflation eases marginally in April; here's what experts have to say